Home / Resource Library / Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin LymphomaAnti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma Results of a study examining CD30 CAR T therapy for the treatment of relapsed Hodgkin lymphoma.